Pharmacologic Use of Niacin

@article{Prousky2011PharmacologicUO,
  title={Pharmacologic Use of Niacin},
  author={Jonathan E. Prousky and Christine G. Millman and J. B. Kirkland},
  journal={Complementary Health Practice Review},
  year={2011},
  volume={16},
  pages={101 - 91}
}
  • Jonathan E. Prousky, Christine G. Millman, J. B. Kirkland
  • Published 2011
  • Biology
  • Complementary Health Practice Review
  • Niacin is required for a host of critical redox and adenosine diphosphate-ribosylation reactions in metabolism. Niacin deficiency leads to the distinctive signs and symptoms of pellagra, but these can happen in an unpredictable progression and can be altered in patients with polymorphisms in any of the hundreds of niacin-dependent enzymes. The symptomatology of niacin deficiency is becoming a forgotten knowledge base, and niacin deficiency is likely underdiagnosed. Additionally, high levels of… CONTINUE READING
    6 Citations

    Figures and Tables from this paper.

    References

    SHOWING 1-10 OF 112 REFERENCES
    Niacin status, NAD distribution and ADP-ribose metabolism.
    • 53
    Niacin deficiency and cancer in women.
    • E. Jacobson
    • Biology, Medicine
    • Journal of the American College of Nutrition
    • 1993
    • 67
    NAD in skin: therapeutic approaches for niacin.
    • 37
    • PDF
    Pellagra Encephalopathy following B-Complex Vitamin Treatment without Niacin
    • 20
    Adverse Effects of Hypolipidaemic Drugs
    • 58
    Biochemical Assessment of Niacin Deficiency Among Carcinoid Cancer Patients
    • 67
    • PDF
    Poly ADP-ribose polymerase-1 and health
    • 40
    Release of markedly increased quantities of prostaglandin D2 in vivo in humans following the administration of nicotinic acid.
    • 211
    GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing.
    • 267
    • PDF